Experimental Approaches to Diabetic Retinopathy (Frontiers in Diabetes Vol.20) (2009. 232 S. 47 fig., 25 in color, 7 tab.)

個数:

Experimental Approaches to Diabetic Retinopathy (Frontiers in Diabetes Vol.20) (2009. 232 S. 47 fig., 25 in color, 7 tab.)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版
  • 商品コード 9783805592758

Full Description

This volume sets the stage for clinical experts working with diabetic patients as well as for researchers by describing the clinical presentations of retinopathy and their anatomical and functional correlates. It reviews currently available experimental models in animals. The impact of retinal pericytes, neuroglia and, specifically, Müller cells are discussed in detail. The volume addresses a variety of current scientific discussions about mechanisms of damage such as growth factors and the VEGF/PEDF balance in the diabetic eye, the ocular renin-angiotensin system, and leukocyte interactions with the microvasculature among others. Stem and progenitor cells in the retina are discussed as potential directions for future investigation. The final chapters return to emerging clinical aspects, including current approaches to retinopathy as a predictor of cardiovascular risk and how knowledge can be translated from bench to bedside. Bridging a widening gap in medical research between basic scientists, who may lose sight of the clinical presentations, and clinical researchers, who may grow unaware of the limits of experimental models, this volume serves as a reference platform for endocrinologists, diabetologists, ophthalmologists, as well as for scientists involved in clinical and basic research in diabetic retinopathy and other vascular complications of diabetes.

Contents

Preface: Hammes, H.-P.; Porta, M.; Clinical Presentations and Pathological Correlates of Retinopathy: Bek, T.; Retinal Vascular Permeability in Health and Disease: Poulaki, V.; In vivo Models of Diabetic Retinopathy: Zheng, L.; Kern, T.S.; Pericyte Loss in the Diabetic Retina: Pfister, F.; Lin, J.; Hammes, H.-P.; Neuroglia in the Diabetic Retina: Bringmann, A.; Reichenbach, A.; Regulatory and Pathogenic Roles of Muller Glial Cells in Retinal Neovascular Processes and Their Potential for Retinal Regeneration: Limb, G.A.; Jayaram, H.; Growth Factors in the Diabetic Eye: Simo, R.; Hernandez, C.; Balance between Pigment Epithelium-Derived Factor and Vascular Endothelial Growth Factor in Diabetic Retinopathy: Ogata, N.; Tombran-Tink, J.; The Renin-Angiotensin System in the Eye: Stroder, K.; Unger, T.; Steckelings, U.M.; Interactions of Leukocytes with the Endothelium: Chavakis, T.; Stem and Progenitor Cells in the Retina: Sengupta, N.; Caballero, S.; Moldovan, N.; Grant, M.B.; Role of Pericytes in Vascular Biology: Armulik, A.; Betsholtz, C.; Current Approaches to Retinopathy as a Predictor of Cardiovascular Risk: Cheung, N.; Liew, G.; Wong, T.Y.; From Bedside to Bench and Back: Open Problems in Clinical and Basic Research: Porta, M.; Hammes, H.-P.; Author Index; Subject Index.

最近チェックした商品